Remove Collective Remove Data Remove Events Remove Topical
article thumbnail

HempFusion Launches Ingestible and Topical CBD Products into Major Arizona Grocer

Cannabis Law Report

(TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce the launch of HempFusion Ingestible and Topical CBD products into nearly 50 retail locations of a major Arizona grocer.

Topical 52
article thumbnail

HempFusion Launches Ingestible and Topical CBD Products into Another Top 15 US Supermarket Chain

Cannabis Law Report

HempFusion’s OTC (Over-the-Counter)) Pain Relief Cream will be added to approximately 400 stores and HempFusion’s Ingestible and Topical CBD products will now be available in 75 targeted stores. HempFusion‘s Co-Founder and Chief Executive Officer. The skin nourishing cream will be available in approximately 400 stores. ABOUT HEMPFUSION.

Topical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

HempFusion Closes Acquisition of Apothecanna

Cannabis Law Report

In addition to FDM and e-commerce, the Transaction provides added distribution channels, increasing HempFusion’s 5 channel strategy to 6 channels and bolstering topical product distribution sales. Robust eCommerce platform drives over 17,000 average monthly sessions, and nearly $2.0 Chief Executive Officer of HempFusion. “We

article thumbnail

A New California Law Will Affect Marijuana and Hemp Businesses Across the Nation

Canna Law Blog

While we’re on the topic of dramatic legal changes, it’s probably a good idea to talk about a California privacy law that’s about to take effect and require many cannabis and hemp companies across the nation to dramatically change their business practices—the California Consumer Privacy Act (or “CCPA”).

article thumbnail

HempFusion Announces USD$2,000,000 Strategic Private Placement

Cannabis Law Report

Built on a foundation of regulatory compliance and human safety, HempFusion Wellness offers a diverse product portfolio comprising of over 75 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. Follow HempFusion on Twitter , Facebook and Instagram.

article thumbnail

HempFusion Provides Corporate Update, Revenue Guidance

Cannabis Law Report

The #1 brand in CBD topicals, with 23% market share in the Drug channel [Drug (IRI-SPINScan 52 week ending 7-11-2021)] and 13.8-per-cent HempFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Retail 111
article thumbnail

InMed Pharmaceuticals Announces Completed Enrollment in Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

Puff Puff Post

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.